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Merkittävä osa lasten päivystyksellisistä käynneistä terveydenhuollon toimipisteissä johtuu 
infektiotaudista tai sen epäilystä. Veren kohonneita valkosolu (leukosyytti)- ja CRP-pitoisuuksia 
pidetään yleisesti epäsuorana viitteenä bakteerin aiheuttamasta elimistön tulehdustilasta. Viime 
vuosina sairaaloiden päivystyspoliklinikoilla yleistyneet valkosolujen ja CRP:n pika- eli vieritestit 
on aikaisemmissa tutkimuksissa osoitettu tarkoiksi ja luotettaviksi testimenetelmiksi, mutta niiden 
taloudellisesta vaikutuksesta ei ole tutkimustietoa. Pikatestien etuna on yksinkertainen näytteenotto, 
joka ei vaadi koulutettua laboratoriohenkilökuntaa sekä muutamien minuuttien kuluessa 
näytteenotosta valmistuva testitulos, mikä mahdollistaa nopeiden hoitopäätösten tekemisen ja 
saattaa lyhentää potilaan polikliinistä hoitoaikaa.
Tämän tutkimuksen tarkoituksena oli arvioida pika-CRP- ja pikaleukosyyttimittausten kustannuksia 
verrattuna perinteisin laboratoriomenetelmin tehtyihin mittauksiin sekä selvittää vieritestauksen 
vaikutusta lapsipotilaiden hoitoaikaan päivystyspoliklinikalla.
Tutkimusaineistona käytettiin retrospektiivisesti kerättyjä 166 lapsen sairauskertomustietoja 
ajanjaksolta elokuu 2012 - lokakuu 2012. Tampereen yliopistollisen sairaalan 
potilastietojärjestelmästä poimittiin niiden lasten tiedot, joiden diagnostiikassa oli 
päivystyspoliklinikalla käytetty pika-CRP- tai pikaleukosyyttimittausta. Pikatestauksen taloudellista 
vaikuttavuutta arvioitiin vertaamalla pikatestien käytöstä aiheutuvien kulujen määrää niihin 
kuluihin, jotka olisivat kertyneet mikäli vastaavat testit olisi tehty laboratoriossa. Hoitoaikaa 
tarkasteltiin suhteessa päivystyspoliklinikalla annettuun hoitoon ja tehtyihin lisätutkimuksiin.
Pikatestien kustannusten havaittiin olevan 41,5% vastaavien laboratioriotestien kustannuksista. 
Niiden potilaiden hoitoaika, joita ei pikatestien ohella tutkittu lisää ja jotka eivät saaneet välittömiä 
hoitotoimia päivystyspoliklinikalla, oli merkitsevästi lyhyempi kuin niiden potilaiden, joille tehtiin 
lisätutkimuksia tai jotka saivat välitöntä hoitoa päivystyspoliklinikalla (mediaani 147,5 vs. 201,5 
min, p< 0,001). 
Tutkimuksen perusteella CRP- ja leukosyyttiarvojen pikamääritys on kustannusvaikuttavaa ja 
oikein kohdistettuna lyhentää hoitoaikaa lasten päivystyspoliklinikalla.
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Abstract
Aim: To evaluate how rapid testing of C-reactive protein (CRP) and white blood cells (WBC) 
influences the patient flow and costs in the pediatric emergency room (ER). 
Methods: The study was a retrospective chart review. In all, 166 children who were treated during 
three months in the ER of a children´s hospital, and in whom rapid tests for WBC and CRP were 
done, were included.  The association between rapid testing and the length of ER stay was 
evaluated, and their costs were compared with corresponding costs if done in hospital laboratory.
Results: The median ER stay lasted 147.5 min, if no other examinations than rapid CRP and WBC 
tests were taken and if no emergency treatments were given, compared with 201.5 min in those with 
other laboratory tests obtained or emergency treatments given (p<0.001). The respective figures 
were 142.5 and 179.5 min in those 96 children discharged home (p=0.003). The costs of rapid 
testing were only 41.5 % of the corresponding costs in laboratory. 
Conclusion: The simultaneous rapid testing of CRP and WBC in children with presumable 
infection decreased the costs and shortened the length of ER stay if no other tests or emergency 
treatment in the ER were needed. The costs of rapid testing were only 41.5 % of the corresponding 
costs in laboratory.
Key words:  C-reactive protein, Cost-effectiveness, Pediatric Emergency Room, Rapid test, White 
blood cell count 
Key Notes: The costs of rapid testing of CRP and WBC were 41.5 % of the corresponding costs in 
laboratory. The median ER stay in 166 children admitted for presumable infections shortened 54 
min (26.8 %), if no emergency treatment in the ER was needed and no other tests than rapid tests 
for CRP and WBC were done. The respective shortening in 96 children discharged home was 37 
min (20.6 %).
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[Introduction]
Elevated white blood cells (WBC) in peripheral blood and C-reactive protein (CRP) in serum are 
often used as nonspecific markers for bacterial etiology of infection in children, although this 
association has been proven only in bacteremic and severe local infections (1-4). In a recent study 
from Norway including more than one million emergency room or home visits in children and 
adults, CRP was studied in 27 % of all contacts, especially in respiratory infections (55 %) and in 
infants (44 %), and particularly by young and inexperienced doctors (5). There is increasing 
evidence that the use of CRP in primary health care has decreased prescribing of antibiotics for 
adults with respiratory infection (6-8), but t in some studies clinical algorithms have worked better 
(9). Corresponding CRP data have not been published in children. 
In western countries, rising costs of health care and health care reforms including centralizing of 
emergency treatment to less and larger units have forced to focus attention on more rapid and less 
costly methods than customary laboratory tests. In addition, the patient flow from the emergency 
room to home or to hospital should be rapid. There are no previous studies on patient flow in child 
patients. 
In some recent years, auto-calibrated rapid test devices have become into clinical use. This 
approach has been called as rapid testing, bed-side testing, near-patient testing or point-of-care 
testing. These devices have been reliable for quantifying serum CRP concentration compared with 
laboratory tests in adults (10) and in children (11). However, less data have been published on the 
reliability of WBC rapid tests (12). Their use shortens the time from sampling to receiving ready 
test results to some minutes, and the decision-making process has accelerated e.g. in the treatment 
of pneumonia in adults (13) and in children (14). 
The rapid test devices for CRP and WBC measurements have been in use in the ER of our 
children`s hospital since 2009.  The aim of the present study was to evaluate the costs of rapid WBC 
and CRP testing, as well as the influence of rapid testing on the length of the ER stay in admitted 
children. 
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Study subjects and methods 
The study was a retrospective hospital chart review. Patients who were treated in the ER of the 
Department of Pediatrics, Tampere University Hospital from 1 August 2012 to 31 October 2012, 
and in whom CRP and/or WBC was determined with rapid tests, were included in the study. One of 
the authors (EK) collected the data from the patient records and electronic files of the hospital. 
Since only register data were used without any contacts to the patients, the head doctor of the 
hospital gave the permission for the study. 
Tampere University Hospital provides as an only hospital pediatric inpatient care and secondary-
level outpatient care for a population of about 90,000 children less than 16 years old. On average, 
6000 patients have been annually treated in the pediatric ER of the hospital, most of them during the 
infection season from November to February. Usually, the children are admitted by general 
practitioners or pediatricians working in the public or private primary care. The doctors working in 
the ER are usually junior physicians who are specializing in pediatrics.
The study period was selected to avoid major epidemics caused by respiratory viruses, such as 
influenza or respiratory syncytial virus  in late autumn or winter. The doctors on duty were advised 
to use the rapid tests available in the ER, if they considered the measurement of WBC and/or CRP 
as indicated, and if it was unlikely that other blood tests were needed. The Afinion AS100 analyzer 
(Axis-Shield PoC AS, Oslo, Norway) was used for CRP and the HemoCue WBC device (HemoCue 
AB, Ängelholm, Sweden) for WBC measurement. 
The measurement range of the CRP device is 5-160 mg/l. The analysis method is based on 
immunometric membrane through-flow assay, and the total assay time is four minutes. The 
measurement range of the WBC device is 0.3-30.0 x10E9/l. The WBC count is determined, after 
hemolyzing of red cells, by colour staining of white cells in a microcuvette. The result is ready in 
three minutes. A self-test for quality control is built-in in both devices, and in addition, the 
laboratory of the hospital studies monthly quality control samples for both CRP and WBC.
CRP and/or WBC rapid tests were studied in 175 children during the three-month study period. 
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Four cases were excluded, since the rapid test results could not be found although the tests had been 
performed. CRP results of 8 children with a rapid test performed with the same device in the 
primary care immediately before admission to the ER were included. WBC results were available in 
171 and CRP results in170 cases. Those 166 children, in whom both WBCs and CRP had been 
studied, form the subjects of the present study.
The data collected from the patient records and electronic files of the hospital included the check-in 
and check-out times, ICD-10 diagnoses (Table S1), CRP and WBC rapid test results, treatments 
given in the ER, and information on the treatment place  (home or hospital). Other diagnostic 
examinations, classified as other blood tests (venous blood samples) and radiological studies (chest 
radiographs) were also recorded. The stay in the ER was registered in minutes. The time of the day 
during which the patient came to the ER was classified into three categories (day time 8.00-14.59, 
evening time 15.00-20.59, and night time 21.00-7.59).
The costs of rapid CRP and WBC tests consisted of leasing and maintenance costs of the devices 
(66.70 euros for the Afinion AS100 CRP analyzer per month, and 56.70 euros for the HemoCue 
WBC analyzer per month) and the use of disposable cuvettes (2.50 euros each, two per patient). The 
laboratory price per sample is 1.30 euros for CRP determination and 1.55 euros for WBC 
determination during office hours, and 2.60 euros and 3.10 euros outside the office hours, 
respectively. In addition, there is a sampling fee of 7.50-22.50 euros depending on the time of the 
day.
We constructed a hypothetical and from the rapid testing point-of-view optimized group of 507 
children admitted to the ER for respiratory infection, tonsillitis or fever without a focus, during the 
3-month study period (Table S1). The number of 507 was a real one obtained from the patient files 
of the hospital. The group was constructed with two assumptions: rapid testing of CRP and WBC 
was performed in all hypothetical patients, and rapid testing was in most cases expected to be 
sufficient without a need for any other tests. However, other laboratory tests were expected to be 
taken in 58 cases (10.8%; the rate received from the 166 study patients with CRP > 120 mg/l or 
WBCs >20x10E9/l).
The data were analyzed with the SPSS 20.0 statistical package (IBM SPSS Statistics). Exploratory 
data analysis revealed that the distributions of age, ER stay, CRP and WBC were non-normally 
distributed. Therefore, the results are expressed as medians, interquartile ranges (IQR) and ranges, 
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as well as in frequency and percentage distributions. The statistical significances of the differences 
were tested with the Mann-Whitney test for continuous and with the Chi square or Fisher`s tests for 
categorized variables. The costs of the rapid tests were compared with the calculated costs in the 
166 patients, if CRP and WBC would have been studied in the laboratory. Further, the results were 
extrapolated to the hypothetical group of 507 children admitted during the study period. 
Results 
The study group consisted of 94 boys (57 %) and 72 girls. The median age was 1.5 years (IQR 0.62-
3.18, range 0.02- 15.3). The check-ins happened during day time in 38.6 %, evening time in 41.6 %, 
and night time in 19.9 % of cases. Thus, 69.9 % of the patients were treated outside the office hours. 
The most common diagnosis was bronchiolitis, followed by upper respiratory infection (Table S1). 
Ninety-four children (56.6 %) needed radiological or laboratory examinations or emergency 
treatment in the ER. Chest radiograph or blood tests in laboratory were studied in 51(30.7 %) cases 
(chest radiographs in 40 and blood tests in laboratory in 18 cases), and 66 (39.8 %) children needed 
emergency treatment (usually salbutamol or adrenalin inhalations). 
The median ER stay was 181.5 min (IQR 135-255, range 15-1983). Children who were transferred 
to hospital or discharged home without other examinations than rapid tests taken and without any 
treatments given stayed (median) 147.5 min (p<0.001 vs. those with other examinations taken or 
treatments given) (Table 1).
In all, 96 (57.8 %) patients were discharged home from the ER, and in 61.7 % of them, rapid CRP 
and WBC tests were the only procedures done. The median ER stay was 142.5 min (p=0.003 vs. 
those with other examinations taken or with treatments given) (Table S2). 
CRP was <20 mg/l and WBCs were <15x10E9/l in 52.4 % of the children.  Either CRP was >120 
mg/l or WBCs were >20x10E9/l in 10.8 % of the cases (Table S3). 
Fifty-one (30.7 %) patients were examined with additional laboratory or radiological studies. 
Additional studies were obtained significantly less often only if CRP was <20 mg/l and WBCs were 
<15.0 x10E9/l (Table 2). If CRP was >20 mg/l or WBCs were >15.0 x10E9/l such association was 
not anymore present (Data not shown).
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Obvious reasons for additional laboratory tests were CRP >120 mg/l or WBCs >20x10E9/l in 4 
cases (Table 2), and an error (outside the measurement range) in the CRP or WBC device in 3 cases 
and abnormally low WBCs in 3 cases (Data not shown). An obvious reason for the examination of 
chest radiograph was CRP >120 mg/l or WBCs >20x10E9/l in 5 cases (Table 2). 
In 166 cases, the costs of CRP and WBC rapid testing were 41.5 % of the costs of corresponding 
laboratory tests. The respective figure was 45.9 % in  the hypothetical group of 507 patients (Table 
3).  
Discussion 
There were two main results in the present study on the impact of rapid CRP and WBC testing in 
the pediatric ER. First, the costs of rapid testing were less than half of the costs if the corresponding 
tests had been made in laboratory. Second, the rapid testing seemed to shorten the length of ER stay. 
The use of rapid tests decreased the costs in the pediatric ER to half when compared with tests in 
laboratory. This result was confirmed by constructing and analyzing a larger, hypothetical study 
group. The use of rapid testing may have an even greater impact on total costs if the reduction of 
unnecessary radiological examinations, over-use of antibiotics and unnecessary hospitalizations are 
taken into account. In a previous adult study (13), the use of bed-side CRP test was not associated 
with reduced hospitalization rate but influenced on taking of chest radiographs and starting of 
antibiotic therapy. In children, rapid testing of CRP and WBCs was useful in separation of bacterial 
from viral pneumonia (14). Two studies performed in primary health care have demonstrated that 
rapid CRP testing has been cost saving in adults with respiratory infection (6,7), due to less use of 
services from the regional laboratory in the study from Denmark (6) and due to less prescribing of 
antibiotics in the study from Norway and Sweden (7).
The use of rapid tests shortened the length of ER stay only if no other laboratory examinations and 
no emergency treatments were needed. This may be explained by the characteristics of the patients 
included in the study. The majority of them suffered from bronchiolitis, wheezy bronchitis or 
asthma exacerbation, often needing emergency treatment in the ER. To our knowledge, no 
previously published data are available on the influence of rapid CRP or WBC testing on the patient 
flow in the pediatric ER. Our results favor the determination of CRP and WBCs using rapid tests in 
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children admitted for respiratory infection to the ER, but to get real benefits, the use of additional 
laboratory tests should be minimized.
The rapid test devices were found as easy to be used, and non-interpretable results were seen in only 
2.5 % of the measurements.  In earlier studies, the agreements between rapid tests and laboratory 
tests for CRP and WBC have been good (10-12). Our finding, that in >10 % of cases both rapid and 
laboratory tests were used, indicates that more precise instructions ought to be given to the doctors 
on duty. For example, 35 % of the additional laboratory tests and chest radiographs were taken 
although rapid WBC and CRP tests were low.  
The study design did not allow to evaluation the influence of rapid CRP or WBC testing on 
hospitalization rates or antibiotic prescribing. There is increasing evidence that making rapid CRP 
test in the primary health care or emergency room has decreased the prescribing of antibiotics for 
respiratory infection in adults (7,8,15). There is an urgent need for corresponding studies applying 
CRP rapid testing in children. 
The results of the present study must be interpreted with caution.  The design of the study was a 
retrospective chart review. On the other hand, this approach may be the only way to study the 
practices of health care. Unfortunately, rapid testing was performed only in about one-third of the 
eligible cases, but this observation is also a result to be taken into account when the practices are 
further developed. 
In conclusion, quantifying the capillary blood CRP and WBC levels by the rapid testing technology 
is possible in a fast and reliable way. Since venipuncture is not needed, rapid testing can be done 
without trained laboratory personnel. Rapid testing is cost saving and can be time saving as well. 
The results encourage to the further use of the CRP and WBC rapid test devices in the pediatric ER, 
as well as in other health care units which treat acutely ill children. 
11
Electronic supplementary material
Table S1.  ICD-10 diagnoses of 166 study patients and 507 hypothetical patients.
Table S2. Length of ER stay, presented in relation to obtaining chest radiographs, laboratory 
examinations and emergency treatment in the ER among the 96 children treated at home.
Table S3. Comparison of categorized CRP and WBC results in 166 study patients.
References 
1. Bass JW, Steele RW, Wittler RR, Weisse ME, Bell V, Heisser AH, et al. Antimicrobial treatment 
of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J 1993; 12: 466-73.
2. Korppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and 
erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997; 10: 
1125–9. 
3. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age 
with clinically undetectable serious bacterial infection. Pediatrics 2001; 108: 1275–9. 
4. Manzano S, Bailey B, Gervaix A, Cousineau J, Delvin E, Girodias JB. Markers for bacterial 
infection in children with fever without source. Arch Dis in Child 2011; 96: 440-6.
5. Rebnord IK, Sandvik H, Hunskaar S. Use of laboratory tests in out-of-hours services in Norway. 
Scand J Prim Health Care 2012; 30: 76-80.
6. Dahler Eriksen BS, Lassen JF, Petersen PH, Lund ED, Lauritzen T, Brandslund I. Evaluation of a 
near-patient test for C-reactive protein used in daily routine in primary health care by use of 
difference plots. Clin Chem 1997; 43: 2064–75. 
7. Oppong R, Jit M, Smith RD, Butler CC, Melbye H, Mölstad S, et al. Cost-effectiveness of point-
of-care C-reactive protein testing to inform antibiotic prescribing decisions. Br J Gen Pract 2013; 
63: e465-71.
8. Bjerrum L, Gahrn-Hansen B, Munck AP. C-reactive protein measurement in general practice may 
lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 2004; 54 :659-62. 
9. Gonzales R, Aagaard EM, Camargo CA Jr, Ma OJ, Plautz M, Maselli JH, et al. C-reactive protein 
testing does not decrease antibiotic use for acute cough illness when compared to a clinical 
algorithm. J Emerg Med 2011; 41: 1-7.
10. Seamark DA, Backhouse SN, Powell R. Field-testing and validation in a primary care setting of 
a point-of-care test for C-reactive protein. Ann Clin Biochem 2003; 40: 178-80. 
11. Esposito S, Tremolati E, Begliatti E, Bosis S, Gualtieri L, Principi N. Evaluation of a rapid 
bedside test for the quantitative determination of C-reactive protein. Clin Chem Lab Med 2005; 43: 
438-40. 
12
12. Osei-Bimpong A, Jury C, McLean R, Lewis SM. Point-of-care method for total white cell 
count: an evaluation of the HemoCue WBC device. Int J Lab Hematol 2009; 31: 657-64. 
13. Flanders SA, Stein J, Shochat G, Sellers K, Holland M, Maselli J, et al. Performance of a 
bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with 
acute cough. Am J Med 2004; 116: 529-35. 
14. Marcus N, Mor M, Amir L, Mimouni M, Waisman Y. Validity of the quick-read C-reactive 
protein test in the prediction of bacterial pneumonia in the pediatric emergency department. Eur J  
Emerg Med 2008; 15: 158-61. 
15. Hoffmann K, Leifheit AK, Reichardt B, Maier M. The antibiotic prescription and redemption 
gap and opportunistic CRP point-of-care testing. A cross-sectional study in primary health care from 
Eastern Austria. Wien Klin Wochenschr 2013; 125: 105-10.
13
Table 1. Length of ER stay, presented in relation to obtaining chest radiographs, laboratory 
examinations and emergency treatment in the ER among 166 study patients.
Number of cases Median Interquartile 
range Q1-Q3
Range P-value
Chest radiograph (N=40) 180.5 min 164-221 67-413 0.980
No chest radiograph (N=126) 183 min 130-264 15-1983 -
Laboratory examinations (N=18) 248.5 min 178-300 67-1983 0.013
No laboratory examinations 
(N=148) 
177 min 132-242 15-981 -
Chest radiograph or laboratory 
examinations (N=51)
185 min 165-240 67-1983 0.190
No chest radiograph or laboratory 
examinations (N=115)
179 min 128-255 15-981 -
Emergency treatment (N=66) 204.5 min 170-264 90-981 0.001
No emergency treatment (N=100) 155 min 100-242 15-1983 -
Chest radiograph, laboratory 
examinations or emergency 
treatment (N=94)
201.5 min 167-264 67-1983 0.000
No chest radiograph, laboratory 
examinations or emergency 
treatment (N=72)
147.5 min 84-238 15-535 -
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Table 2. Obtaining of chest radiographs and laboratory examination in relation to combined rapid 
CRP and WBC test results. 
CRP and WBC 
results
Chest 
radiograph 
obtained 
(n=40)
Laboratory 
tests 
obtained 
(n=18)
Chest 
radiograph 
or 
laboratory 
tests 
obtained 
(n=48)
P-value No chest 
radiograph 
or 
laboratory 
tests 
obtained 
(n=114)
WBC <15 
x10E9/l and CRP 
<20 mg/l  (n=87)
12 (13.8%) 6 (6.9%) 17 (19.5%) 0.0021 70 (80.5%)
WBC >20 x109/l 
or CRP >120 
mg/l  (n=18)
5 (27.8%) 4 (22.2%) 7 (38.9%) 0.3622 11 (61.1%)
1 compared to children with WBC >15 x10E9/l or CRP >20 mg/l  
2 compared to children with WBC <20 x10E9/l and CRP < 120 mg/l  
Table 3. Costs in 166 study patients and in 507 hypothetical calculated patients. 
Patient groups Leasing costs + 
cuvettes
Costs of additional 
laboratory tests
CRP and WBC 
prices + sampling 
fees
All costs
Laboratory testing 
n=166
- - 3789 € 3789 €
Rapid testing 
n=166
1199 € 374 € - 1573 €
Laboratory testing 
n=507
- - 8821 € 8821 €
Rapid testing 
n=507
2904 € 1148 € - 4052 €
15
Table S1. ICD-10 diagnoses of 166 study patients and 507 hypothetical patients. 
Diagnosis Study patients (N=166) Hypothetical patients (N=507)
Bronchiolitis (J21.9) 51 (30.7%) 136 (26.8%)
Upper respiratory tract 
infection (J06.9)
19 (11.4%) 83 (16.3%)
Pneumonia  (J18) 12 (7.2%) 54 (10.7%)
Wheezy bronchitis 
(J45.1)
12 (7.2%) 44 (8.7%)
Non-specified 
infection (B34.9)
10 (6.0%) 43 (8.5%)
Otitis media (H66.0) 10 (6.0%) 44 (8.7%)
Tonsillitis acuta 
(J03.9)
3 (1.8%) 49 (9.7%)
Non-specified febrile 
illness (R50.9)
4 (2.4%) 54 (10.7%)
Others ¹ 45 (27.1%) 0 (0.0%)
 
¹ Pyelonefritis N10 (n=8), Non-specified symptoms R68.1 (n=4), Gastroenteritis A08 (n=3), 
Laryngitis J04 (n=3), Pneumococcemia A40.3 (n=2), Cystitis N30 (n=2), Unspecified urinary tract 
infection N39 (n=2), Infant regurgitation P92.1 (n=2), Nausea R11 (n=2), Medical observation 
Z03.9 (n=2) and 15 other sporadic diagnoses.
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Table S2. Length of ER stay, presented in relation to obtaining chest radiographs, laboratory 
examinations and emergency treatment in the ER among the 96 children treated at home.
Number of cases Median Interquartile 
range Q1-Q3
Range P-value
Chest radiograph (N=20) 172.5 min 146.75-207.25 100-413 0.404
No chest radiograph (N=76) 154.5 min 100-255 15-1983 -
Laboratory examinations (N=5) 181 min 144-1129.50 118-1983 0.235
No laboratory examinations 
(N=91) 
155 min 110-240 15-535 -
Chest radiograph or laboratory 
examinations (N=24)
175 min 146.75-229.50 100-1983 0.172
No chest radiograph or laboratory 
examinations (N=72)
152 min 98.50-253.75 15-535 -
Emergency treatment (N=20) 190 min 158.25-285 115-385 0.008
No emergency treatment (N=76) 150 min 100-227 15-1983 -
Chest radiograph, laboratory 
examinations or emergency 
treatment (N=38)
179.50 min 149.50-271.50 100-1983 0.003
No chest radiograph, laboratory 
examinations or emergency 
treatment (N=58)
142.50 min 73.50-219 15-535 -
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Table S3. Comparison of categorized CRP and WBC results in 166 study patients
CRP Total
5-19 
mg/l
20-59 
mg/l
60-119 
mg/l
≥120 
mg/l
Error1
WBC <15.0 
x10E9/l
87 
(52.4%)
26 
(15.7%)
8 (4.8%) 3 (1.8%) 1 (0.6%) 125 
(75.3%)
15.0-19.9 
x10E9/l
9 
(5.4%)
7 (4.2%) 7 (4.2%) 2 (1.2%) 0 (0.0%) 25 (15.1%)
≥20.0 
x10E9/l
4 
(2.4%)
5 (3.0%) 3 (1.8%) 1 (0.6%) 1 (0.6%) 14 (8.4%)
Error1 0 
(0.0%)
2 (1.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (1.2%)
Total 100 
(60.2%)
40 
(24.1%)
18 
(10.8%)
6 (3.6%) 2 (1.2%) 166 (100%)
1 Outside the determination range
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